Interval Training in Adults With Congenital Heart Disease a Randomized Trial
Effect of Home Based Interval Training on Exercise Capacity and Quality of Life in Adults With Congenital Heart Disease - a Randomized Controlled Multicenter Trial
Visão geral do estudo
Status
Condições
Intervenção / Tratamento
Descrição detalhada
The number adults with congenital heart disease is increasing. Thanks to advances in the medical and surgical fields the number of adults with complex congenital heart disease is now higher than the children with corresponding heart disease. Though the long term prognosis is still unknown and continuously changing as new therapeutic options are introduced.
Persons with congenital heart disease have different degrees of impaired exercise capacity compared to healthy controls. Some studies indicate that this population is not sufficiently active to achieve the recommendations for physical activity in preventing acquired heart disease. Physical inactivity is an important risk factor for developing acquired heart disease and other life style diseases as obesity and diabetes. In a population where one or more previous cardiac surgeries are common, the prevention of life style diseases is especially important. Exercise training in heart failure and coronary artery disease is well studied and there are clinical guidelines. Regarding exercise training in adults with congenital heart disease, however,the information is sparse and further studies are needed.
Based on defined inclusion and exclusion criteria adults with complex congenital heart disease will be recruited in the Northern Health Care Region in Sweden and in Gothenburg. Before and after the twelve week intervention period the investigators will collect information about cardiopulmonary exercise capacity, health related quality of life, exercise self-efficacy, anxiety and depression. The patients will be randomized to twelve weeks of home based interval training or to a control group. The randomization ratio will be 2:1 (intervention:control). The control group will be instructed to continue with their habitual physical activities. The home based interval training program will be individualized based on the results of the exercise tests.
The aim of this study is to examine the effect of home based interval training on maximal and submaximal exercise capacity, quality of life, exercise self-efficacy, anxiety and depression.
Tipo de estudo
Inscrição (Real)
Estágio
- Não aplicável
Contactos e Locais
Locais de estudo
-
-
-
Gothenburg, Suécia, SE- 413 45
- Sahlgrenska University Hospital
-
Umeå, Suécia, 90185
- University Hospital
-
-
Critérios de participação
Critérios de elegibilidade
Idades elegíveis para estudo
Aceita Voluntários Saudáveis
Gêneros Elegíveis para o Estudo
Descrição
Inclusion Criteria:
- Complex congenital heart disease (e.g.; Tetralogy of Fallot, Transpositions of the great arteries, Ebstein, Eisenmenger, Pulmonary atresia or Tricuspid atresia)
- Clinically stable without significant change the last 3 months
- Adult (>18 years)
- Informed consent
Exclusion Criteria:
- Signs of arrhythmia on exercise ECG or relevant clinical arrhythmia
- Mental retardation or psychiatric illness affecting the ability of independent decisions
- Other comorbidity affecting physical activity
- Other circumstances making participation unsuitable
- Present strategy of regularly executing physical exercise > 2 times/week in purpose to increase cardiovascular capacity.
- VO2 peak > 30 ml/kg/min
- No access to internet
Plano de estudo
Como o estudo é projetado?
Detalhes do projeto
- Alocação: Randomizado
- Modelo Intervencional: Atribuição Paralela
- Mascaramento: Solteiro
Armas e Intervenções
Grupo de Participantes / Braço |
Intervenção / Tratamento |
|---|---|
|
Experimental: Home based interval training
12 weeks home based interval training
|
The participant in the intervention group will receive an individualized interval training program.
The individualized adjustments in training load will be made from the results of the CPET-incremental and adjustments in training time from the results of the constant work rate 75% of peak work rate (Watt).
The training will be home based and performed on a ergometer cycle 3 times a week for twelve weeks.
During exercise they will wear a heart rate monitoring watch.
The registered heart rate will be transferred to a webpage after the exercise session.
Only the physiotherapist and participant have the access to this page.
The physiotherapist and participant will have a weekly contact to promote compliance, provide feedback and if necessary adjust the training time or load.
Progression in training load and time will be made when necessary to keep a relevant intensity.
|
|
Sem intervenção: Control group
No structured exercise training.
|
O que o estudo está medindo?
Medidas de resultados primários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Peak VO2 (ml/kg/min)
Prazo: Before homebased interval exrecise regime and after completion (12 weeks)
|
Comparison within and between groups
|
Before homebased interval exrecise regime and after completion (12 weeks)
|
|
Endurance time
Prazo: Before homebased interval exercise regimen and at completion (12 weeks)
|
at CPET-incremental and constant work rate test at 75% of peak work rate (Watt).
Comparison between and within groups.
|
Before homebased interval exercise regimen and at completion (12 weeks)
|
Medidas de resultados secundários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Response during CPET incremental and constant work rate test at 75% of peak work rate (Watt).
Prazo: Before homebased interval exercise regime and at completion (12 weeks)
|
(Peak VO2 (l/min) and Iso time, VCO2, VE/VCO2, VE/VCO2-slope, anaerobic threshold, Peak Heart Rate, Heart Rate recovery, Heart Rate response, Peak work rate, Oxygen saturation, Blood pressure, symptoms) Comparison within and between groups.
|
Before homebased interval exercise regime and at completion (12 weeks)
|
|
Adverse events
Prazo: Once a week during homebased exercise regime
|
Complications to training
|
Once a week during homebased exercise regime
|
|
Quality of life
Prazo: Before homebased interval exercise regime and at completion (12 weeks)
|
The EQ-5D and SF 36 questionaires will be used to assess Quality of life.
Comparison between and within groups.
|
Before homebased interval exercise regime and at completion (12 weeks)
|
|
Physical activity level
Prazo: Before homebased interval exercise regime and after completion (12 weeks)
|
The long self administered version of International Physical Activity Questionaire (IPAQ) will be used to assess physical activity level.
Comparison within and between groups.
|
Before homebased interval exercise regime and after completion (12 weeks)
|
|
Exercise self-efficacy
Prazo: Before homebased interval exercise regime and after completion
|
The Exercise Self-Efficacy Scale will be used.
Comparison within and between groups
|
Before homebased interval exercise regime and after completion
|
|
Anxiety and depression
Prazo: Before homebased interval exercise regime and after completion (12 weeks)
|
The hospital anxiety and depression scale (HAD-scale) will be used to estimate the incidence of anxiety and depression.
Comparison between and within groups.
|
Before homebased interval exercise regime and after completion (12 weeks)
|
|
Response during CPET incremental and constant work rate test at 75 % of peak work rate (Watt).
Prazo: 12 months after completion
|
( Peak VO2 and Iso time(l/min), VCO2, VE/VCO2, VE/VCO-slope, anaerobic threshold, Peak Heart Rate, Heart Rate recovery, Heart rate response, Peak work rate, Oxygen saturation, Blood pressure, symptoms) Comparison within and between groups.
|
12 months after completion
|
|
Peak VO2( ml/kg/min)
Prazo: 12 months after completion
|
Comparison within and between groups
|
12 months after completion
|
|
Endurance time
Prazo: 12 months after completion
|
at CPET incremental and constant work rate at 75% of peak work rate (Watt)
|
12 months after completion
|
|
Quality of life
Prazo: 12 months after completion
|
The EQ-5D and SF 36 questionaires will be used to assess Quality of life.
Comparison within and between groups.
|
12 months after completion
|
|
Physical Activity level
Prazo: 12 months after completion
|
The long self administered version of International Physical Activity Questionaire (IPAQ) will be used to assess physical activity level.
Comparison within and between groups.
|
12 months after completion
|
|
Anxiety and depression
Prazo: 12 months after completion
|
The hospital Anxiety and Depression Scale (HAD-scale) will be used to estimate the incidence of anxiety and depression.
Comparison within and between groups.
|
12 months after completion
|
Colaboradores e Investigadores
Patrocinador
Investigadores
- Investigador principal: Bengt Johansson, MD, Phd, Umeå University
Datas de registro do estudo
Datas Principais do Estudo
Início do estudo
Conclusão Primária (Real)
Conclusão do estudo (Real)
Datas de inscrição no estudo
Enviado pela primeira vez
Enviado pela primeira vez que atendeu aos critérios de CQ
Primeira postagem (Estimativa)
Atualizações de registro de estudo
Última Atualização Postada (Estimativa)
Última atualização enviada que atendeu aos critérios de controle de qualidade
Última verificação
Mais Informações
Termos relacionados a este estudo
Palavras-chave
Termos MeSH relevantes adicionais
Outros números de identificação do estudo
- GUCHUmU01
Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .